STEP TEENS: Semaglutide for teens | Hormone Insight Podcast
Items couldn't be added
The title couldn't be added to your basket.
Couldn't add title to Wish List
‘Remove from Wish List’ failed
Adding to library failed
‘Follow podcast’ failed
‘Unfollow podcast’ failed
STEP TEENS: Semaglutide for teens | Hormone Insight Podcast
-
Narrated by:
-
By:
Does once-weekly 2.4 milligram subcutaneous semaglutide plus lifestyle intervention reduce BMI more than lifestyle intervention alone in adolescents with obesity?
In adolescents with obesity, once-weekly 2.4 mg subcutaneous semaglutide plus lifestyle intervention reduced BMI more than lifestyle intervention alone over 68 weeks, by about 17 percentage points.
Randomized trial · NEJM 2022
Reference: Weghuber D, Barrett T, Barrientos-Pérez M. Once-Weekly Semaglutide in Adolescents with Obesity. N Engl J Med. 2022; PMID:36322838.
Chapters
0:00 Intro
0:38 The trial
3:14 My take
3:43 Outro
Read the structured trial summary at https://hormoneinsight.com/
AI-generated narration. This podcast is intended for healthcare professionals and is for educational purposes only; it is not medical advice. Any views expressed are the presenter's own and do not necessarily reflect the views of any institution he works with.
Explore Hormone Insight:
Website: https://hormoneinsight.com/
Apple App Store: https://apps.apple.com/sa/app/hormone-insight/id6749515856
Google Play: https://play.google.com/store/apps/details?id=com.fahadwali78.hormoneinsightmobile&hl=en